FIELD: medicine.
SUBSTANCE: method involves carrying out excretion cystometry with total action potential of motor units of perineal muscles and muscles of external anal sphincter being recorded using skin electrodes. Obstructive urination diagnosis being confirmed with excretion cystometry data and total action potential of motor units increment being greater than 500 mcV, myorelaxant agent central action mechanism like tizanidine is administered at a dose of 24 mg per day taken in three portions (8 mg three times a day).
EFFECT: enhanced effectiveness in eliminating sphincter dysfunction; prevented disease recurrence.
2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING BENIGN HYPERPLASIA OF PROSTATE GLAND | 2012 |
|
RU2489093C1 |
| METHOD FOR PREDICTING INFRAVESICAL OBSTRUCTION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA | 2006 |
|
RU2315550C1 |
| METHOD OF PROVIDING ACCESS TO A SURGICAL OBJECT WHEN PERFORMING PLASMA TRANSURETHRAL ENUCLEATION OF BENIGN PROSTATIC HYPERPLASIA | 2019 |
|
RU2700488C1 |
| METHOD FOR VISUALIZING EFFICIENCY OF TREATMENT OF BENIGN PROSTATIC HYPERPLASIA | 2018 |
|
RU2681508C1 |
| METHOD FOR DIAGNOSING INFRAVESICAL OBSTRUCTION CASES | 2006 |
|
RU2301624C1 |
| LASER THERAPY METHOD FOR TREATING BENIGN PROSTATE HYPERPLASIA CASES | 2005 |
|
RU2295365C1 |
| METHOD FOR DETECTING THE TYPE FOR TREATING PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA | 2001 |
|
RU2205001C2 |
| METHOD FOR INTERMITTENT THERAPY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA | 2013 |
|
RU2531944C1 |
| METHOD FOR MONITORING REMOTE REHABILITATION PERIOD AFTERCARE AFTER TRANSURETHRAL PROSTATE RESECTION AND CLASSIC ADENECTOMY IN THE CASES OF INSUFFICIENT SATISFACTION WITH OPERATION RESULTS | 2001 |
|
RU2242230C2 |
| AGENT FOR PREVENTING AND TREATING PROSTATITIS AND PROSTATE ADENOMA | 2013 |
|
RU2538615C1 |
